Neus Basté

4.2k total citations
32 papers, 335 citations indexed

About

Neus Basté is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Neus Basté has authored 32 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Otorhinolaryngology and 7 papers in Surgery. Recurrent topics in Neus Basté's work include Head and Neck Cancer Studies (18 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Lung Cancer Research Studies (7 papers). Neus Basté is often cited by papers focused on Head and Neck Cancer Studies (18 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Lung Cancer Research Studies (7 papers). Neus Basté collaborates with scholars based in Spain, United States and Japan. Neus Basté's co-authors include Ricard Mesı́a, Danny Rischin, Amanda Psyrri, Tamara Rordorf, Brett Hughes, Makoto Tahara, Prakash Neupane, Christophe Le Tourneau, Denis Soulières and Richard Greil and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Neus Basté

28 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neus Basté Spain 10 213 142 114 81 56 32 335
Avgust M. Garin Russia 4 276 1.3× 164 1.2× 177 1.6× 77 1.0× 101 1.8× 7 408
D. Spielsinger United States 5 268 1.3× 91 0.6× 125 1.1× 76 0.9× 23 0.4× 11 352
Eve‐Marie Neidhardt France 9 104 0.5× 100 0.7× 71 0.6× 55 0.7× 83 1.5× 28 249
Felix Ho United States 8 198 0.9× 69 0.5× 81 0.7× 121 1.5× 34 0.6× 16 298
Jia-Wei Lv China 7 138 0.6× 40 0.3× 95 0.8× 51 0.6× 63 1.1× 8 268
Susie Su Canada 9 130 0.6× 119 0.8× 45 0.4× 107 1.3× 105 1.9× 11 310
Dtt Chua China 7 151 0.7× 229 1.6× 88 0.8× 181 2.2× 76 1.4× 10 352
Shang‐Hang Xie China 9 176 0.8× 150 1.1× 47 0.4× 68 0.8× 76 1.4× 15 355
Yonglin Cai China 10 149 0.7× 110 0.8× 46 0.4× 33 0.4× 99 1.8× 30 300
Yue‐Feng Wen China 10 133 0.6× 181 1.3× 75 0.7× 117 1.4× 86 1.5× 17 344

Countries citing papers authored by Neus Basté

Since Specialization
Citations

This map shows the geographic impact of Neus Basté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neus Basté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neus Basté more than expected).

Fields of papers citing papers by Neus Basté

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neus Basté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neus Basté. The network helps show where Neus Basté may publish in the future.

Co-authorship network of co-authors of Neus Basté

This figure shows the co-authorship network connecting the top 25 collaborators of Neus Basté. A scholar is included among the top collaborators of Neus Basté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neus Basté. Neus Basté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caballero, Miguel, Juan J. Grau, Neus Basté, et al.. (2025). Cancer stem cell biomarkers in locally advanced head and neck squamous cell carcinoma. Brazilian Journal of Otorhinolaryngology. 91(6). 101689–101689.
2.
Alonso‐Gordoa, Teresa, Paula Jiménez‐Fonseca, Javier Martínez‐Trufero, et al.. (2024). SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023). Clinical & Translational Oncology. 26(11). 2902–2916. 1 indexed citations
3.
Arrazubi, Virginia, Neus Basté, Irene Braña, et al.. (2024). TTCC-2022-01: Niraparib and dostarlimab in locally-advanced head and neck squamous cell carcinoma treated with (chemo) radiotherapy (RADIAN).. Journal of Clinical Oncology. 42(16_suppl). TPS6125–TPS6125. 2 indexed citations
4.
Vilaseca, Isabel, Francesc Xavier Avilés‐Jurado, Eduardo Lehrer, et al.. (2022). CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy. Oral Oncology. 134. 106088–106088. 5 indexed citations
5.
Medrano-Martorell, Santiago, Juan Berenguer, África Muxí, et al.. (2022). Persistent lymph nodes after curative chemoradiotherapy for head and neck cancer: imaging predictors of response for decision-making. European Archives of Oto-Rhino-Laryngology. 280(3). 1369–1379.
6.
Terra, Ximena, Victòria Ceperuelo‐Mallafré, Ramón Bosch, et al.. (2021). Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker. Cancers. 13(7). 1653–1653. 21 indexed citations
7.
Saleh, Khalil, Anne Aupérin, Nicolas Martin, et al.. (2021). Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck. European Journal of Cancer. 157. 190–197. 10 indexed citations
8.
Psyrri, Amanda, Hisham Mehanna, Panagiota Economopoulou, et al.. (2021). 929TiP HERODOTUS: Head and neck cancers international COVID-19 collaboration: An international registry on head and neck cancer with COVID-19. Annals of Oncology. 32. S815–S815.
9.
Gomez‐Roca, Carlos, Caroline Even, Christophe Le Tourneau, et al.. (2021). Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer. Clinical and Translational Science. 15(1). 55–62. 17 indexed citations
10.
Kristeleit, Rebecca, Víctor Moreno, Valentina Boni, et al.. (2021). Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study. International Journal of Gynecological Cancer. 31(11). 1428–1436. 6 indexed citations
11.
Basté, Neus, Mireia Mora, & Juan J. Grau. (2021). Emerging systemic antitarget treatment for differentiated thyroid carcinoma. Current Opinion in Oncology. 33(3). 184–195. 5 indexed citations
12.
Bluthgen, M.V., Neus Basté, & Gonzalo Recondo. (2020). Immunotherapy Combinations for the Treatment of Patients with Solid Tumors. Future Oncology. 16(23). 1715–1736. 7 indexed citations
13.
14.
15.
Pai, Sara I., Ezra E.W. Cohen, Derrick Lin, et al.. (2019). SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Journal of Translational Medicine. 17(1). 429–429. 6 indexed citations
16.
Even, Caroline, Neus Basté, & Marion Classe. (2019). New approaches in salivary gland carcinoma. Current Opinion in Oncology. 31(3). 169–174. 8 indexed citations
17.
Plana, Nieves, et al.. (2017). Does hyper-progression exist among head and neck cancer patients treated with immunotherapy?. Annals of Oncology. 28. v379–v379. 3 indexed citations
18.
19.
Pai, Sara I., Ezra E.W. Cohen, Derrick Lin, et al.. (2017). RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN). Annals of Oncology. 28. v374–v375. 4 indexed citations
20.
Basté, Neus, Irene Braña, Cristina Viaplana, et al.. (2017). Impact of early trials in molecularly-characterized patients (pts) with head and neck cancer (HNC).. Journal of Clinical Oncology. 35(15_suppl). 6031–6031. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Avgust M. Garin Breakdown of academic impact, for papers by D. Spielsinger Breakdown of academic impact, for papers by Eve‐Marie Neidhardt Breakdown of academic impact, for papers by Felix Ho Breakdown of academic impact, for papers by Jia-Wei Lv Breakdown of academic impact, for papers by Susie Su Breakdown of academic impact, for papers by Dtt Chua Breakdown of academic impact, for papers by Shang‐Hang Xie Breakdown of academic impact, for papers by Yonglin Cai Breakdown of academic impact, for papers by Yue‐Feng Wen
Rankless by CCL
2026